Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1452765 NEW YORK, NY

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$776,086
-$412,623 QoQ
Shares Held
1,738
-33.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Sep 30, 2024
CallValue
$6,557,628
CallShares
14,100
PutValue
$5,255,404
PutShares
11,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GTS SECURITIES LLC holds $7,337,364 across 30 Biotechnology names. VRTX ranks #1 (10.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
1,738 $776,086

All Filings in VRTX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $776,086 1,738
2025-12-31 $1,188,709 2,622
2025-09-30 $2,245,663 5,734
2025-06-30 $733,689 1,648
2025-03-31 $1,001,638 2,066
2024-12-31 $1,340,588 3,329
2024-09-30 $6,557,628 14,100
2024-09-30 $2,086,813 4,487
2024-09-30 $5,255,404 11,300
2024-06-30 $937,440 2,000
2024-06-30 $9,655,632 20,600
2024-06-30 $6,749,568 14,400
2024-03-31 $9,906,837 23,700
2024-03-31 $245,371 587
2024-03-31 $5,141,523 12,300
2023-12-31 $10,986,030 27,000
2023-12-31 $4,964,058 12,200
2023-12-31 $2,576,020 6,331
2023-09-30 $8,623,952 24,800
2023-09-30 $1,043,220 3,000